Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignancy with limited treatment options. The evidence for the use of immunotherapy in ACC has been conflicting, with overall response rates ranging from 6 – 33%. CASE PRESENTATION: We describe the case of a 32 year old patient who was initially...

Descripción completa

Detalles Bibliográficos
Autores principales: Charles, Rebecca, Madhu, Divine, Powles, Alexander, Boyde, Adam, Hughes, Owen, Kumar, Nagappan, Moorcraft, Sing Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516602/
https://www.ncbi.nlm.nih.gov/pubmed/37746287
http://dx.doi.org/10.3389/fonc.2023.1242560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516602/
https://www.ncbi.nlm.nih.gov/pubmed/37746287
http://dx.doi.org/10.3389/fonc.2023.1242560

Ejemplares similares